Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 564-573

  Kobayashi, Kazuo ^a   Yamazaki, Junko ^b   Kasama, Tsuyoshi ^b   Katsura, Takashi ^b   Kasahara, Keita ^b   Wolf, Stanley F ^b   Shimamura, Tadakatsu ^b  

^a SHOWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

EID: 0029763305     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.564     Document Type: Article

References (18)

1. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-8.
2. Wallace RJ, O'Brien R, Glassroth J, Raleigh J, Dutt A. Diagnosis and treatment of disease caused by Mycobacterium avium-intracellulare. Am Rev Respir Dis 1990;142:940-53.
3. Skamene E. Genetic control of susceptibility to mycobacterial infections. Rev Infect Dis 1989;11(suppl 2):S394-9.
4. Curtis J, Turk JL. Resistance to subcutaneous infection with Mycobacterium lepraemurium is controlled by more than one gene. Infect Immun 1984;43:925-30.
5. Goto Y, Nakamura RM, Takahashi H, Tokunaga T. Genetic control of resistance to Mycobacterium intracellulare infection in mice. Infect Immun 1984;46:135-40.
6. Orme IM, Stokes RW, Collins FM. Genetic control of natural resistance to nontuberculous mycobacteria infections in mice. Infect Immun 1986;54:56-62.
7. Gros P, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 1981;127:2417-21.
8. Kakinuma K, Yamamoto K. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Demonstration of two types of low responders. Immunology 1985;55:91-7.
9. Pelletier M, Forget A, Bourassa D, Gros P, Skamene E. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J Immunol 1982;129:2179-85.
10. Brett S, Orrell JM, Swanson Beck J, Ivanyi J. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 1992;76:129-32.
11. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-63.
12. Britton WJ, Roche PW, Winter N. Mechanisms of persistence of mycobacteria. Trends Microbiol 1994;2:284-8.
13. Dannenberg AM Jr. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991;12:228-33.
14. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
15. Oppenheim JJ, Neta R. Pathophysiological roles of cytokines in development, immunity, and inflammation. FASEB J 1994;8:158-62.
16. Doi T, Ando M, Akaike T, Suga M, Sato K, Maeda H. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect Immun 1993;61:1980-9.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
18. Kasama T, Stricter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995;95:2868-76.